Sinensetin ameliorates established high-fat diet-induced liver injury and intestinal barrier dysfunction through the mitophagy/TLR4/MAPK signaling pathway.
Аннотация
INTRODUCTION
Long-term consumption of a high-fat diet (HFD) causes liver injury characterized by steatosis, inflammation, and fibrosis. Mitophagy, as a selective autophagy, is reported to be involved in the regulation of liver injury. Sinensetin, a polymethoxylated flavonoid abundant in citrus fruit peels, exhibits various biological activities, including anti-inflammatory and hepatoprotective properties. However, whether sinensetin can target mitophagy and protect against HFD-induced liver damage via the gut-liver axis remains inadequately explored.
METHODS
In order to further investigate the relationships involved, we conducted histopathology analysis, biochemical analysis, 16S rRNA sequencing, and short-chain fatty acid (SCFA) levels.
RESULTS
Sinensetin administration ameliorated hepatic steatosis, inflammation, and restored intestinal integrity in HFD-fed mice. Mechanistically, sinensetin remodeled the gut microbiota, elevating SCFA levels, which activated mitophagy and cleared damaged mitochondria in liver and intestinal tissues, thereby suppressing the toll-like receptor 4 (TLR4)/mitogen-activated protein kinase (MAPK) signaling.
CONCLUSION
Sinensetin may contribute to protecting against HFD-induced liver injury and intestinal barrier dysfunction by orchestrating the integrated "microbiota-SCFA-mitophagy" defensive network, providing a novel paradigm beyond the classical TLR4/MAPK axis.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.